Advertisements



Allergan kills talk of mega takeover bid for Shire

Drug-making giant Allergan says it has no plans to make a massive bid for biotech firm Shire, the latest twist in a saga that has played havoc with the companies' share prices......»»

Category: marketsSource: cnnApr 20th, 2018

Shire drops 3.3% after Allergan backs away from takeover offer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 20th, 2018

Fast-Growing Shire Had Pharmaceutical Rivals in a Takeover Frenzy

Drugmaker Shire rebuffed a takeover bid from rival Takeda Pharmaceutical, then Allergan took a look......»»

Category: smallbizSource: wsjApr 20th, 2018

Fast-Growing Shire PLC Had Pharmaceutical Rivals in a Takeover Frenzy

Drugmaker Shire PLC rebuffed a takeover bid from rival Takeda Pharmaceutical Co., then Allergan PLC took a look......»»

Category: smallbizSource: wsjApr 19th, 2018

A bidding war for the maker of Adderall stalled out after just 4 hours (SHPG, TKPYY, AGN)

Shire rejected Takeda's $60 billion takeover bid on Thursday morning. Allergan then confirmed it was "in the early stages of considering a possible offer" for Shire, potentially creating a bidding wa.....»»

Category: topSource: businessinsiderApr 19th, 2018

CNBC: Allergan-Shire Deal Is DOA

Allergan plc (NYSE: AGN) stock was volatile Thursday after CNBC reported the firm will not pursue a Shire PLC (ADR) (NASDAQ: SHPG) takeover, citing sources. .....»»

Category: blogSource: benzingaApr 19th, 2018

A bidding war is brewing over $50 billion drugmaker Shire (SHPG, TKPYY, AGN)

Reuters Shire rejected Takeda's $60 billion takeover bid on Thursday. Allergan then .....»»

Category: topSource: businessinsiderApr 19th, 2018

The next mega merger could be a $60 billion drug deal

Shares in drug company Shire surged in London as Japan's Takeda and Allergan consider bidding......»»

Category: topSource: cnnApr 19th, 2018

Allergan Mulls Bid for Drugmaker Shire After $60 Billion Takeda Offer

A potential bidding war for drugmaker Shire erupted after Japan’s Takeda said it made a $60 billion takeover offer and U.S. rival Allergan said it was considering making its own bid......»»

Category: smallbizSource: wsjApr 19th, 2018

Allergan moves in as Shire rebuffs $63 billion Takeda bid: sources

NEW YORK/LONDON (Reuters) - Drugmaker Shire has rejected a third takeover bid worth nearly $63 billion from Japan's Takeda Pharmaceutical , although talks are continuing, while sources said Allergan was also in competing negotiations......»»

Category: topSource: reutersApr 19th, 2018

Shire: Were Earnings Good Enough To Warrant Takeover Talk?

Shire: Were Earnings Good Enough To Warrant Takeover Talk?.....»»

Category: topSource: seekingalphaApr 27th, 2018

Europe Markets: Carrefour shares slump as Couche-Tard’s short pursuit ends while European stocks and U.S. futures drift

Shares of Carrefour slumped 7% on Monday, after Canada's Couche-Tard ended its short-lived takeover talk to buy the French supermarket giant......»»

Category: topSource: marketwatchJan 18th, 2021

Warren Buffett is waiting to deploy a $137 billion cash pile for a future mega-deal. Here are Berkshire Hathaway"s 10 biggest acquisitions so far.

Rick Wilking/Reuters Warren Buffett's Berkshire Hathaway hasn't closed a major takeover since 2016, and the holding company's ammunition for such a deal is building up. Berkshire has $137 billion to deploy for its nex.....»»

Category: topSource: businessinsiderMay 14th, 2020

Why AbbVie Might Fall After The Mega-Merger With Allergan

Why AbbVie Might Fall After The Mega-Merger With Allergan.....»»

Category: topSource: seekingalphaNov 26th, 2019

Timeline: LSE - A story of failed mega-mergers

The London Stock Exchange emphatically rejected a $39 billion takeover offer from the Hong Kong bourse on Friday, opting to stick with its planned purchase of data and analytics group Refinitiv......»»

Category: topSource: reutersSep 13th, 2019

LSE: A story of failed mega mergers

Hong Kong Exchanges and Clearing made an unsolicited $39 billion takeover bid for the London Stock Exchange , an offer contingent on the LSE ditching its planned acquisition of data company Refinitiv......»»

Category: topSource: reutersSep 11th, 2019

AbbVie Is Buying Botox Maker Allergan in Blockbuster $63 Billion Deal

It's the latest mega-deal in the health space. AbbVie is buyi.....»»

Category: europeSource: fortuneJun 25th, 2019

Greg Hayes,Tom Kennedy UTX & RTN CEOs Talk Mega-Merger

CNBC Transcript: United Technologies Corporation (NYSE:UTX) Chairman and CE.....»»

Category: blogSource: valuewalkJun 10th, 2019

Takeda sells dry eye drug to Novartis to help cut debt

Takeda Pharmaceutical Co Ltd agreed to sell its dry eye drug to Swiss drugmaker Novartis AG for $3.4 billion and potential milestone payments of up to $1.9 billion, in the first divestment since its takeover of Britain's Shire......»»

Category: topSource: reutersMay 9th, 2019

Global Stocks Hit 6 Month High On, Drumroll, Renewed "Trade Talk Optimism"

This is the part in Groundhog Day where Phil Connors kills himself again, and again, and again. Wit.....»»

Category: blogSource: zerohedgeApr 15th, 2019

The Auto Industry Is Overdue a Bout of Mega-Mergers

The sector desperately needs to consolidate and reduce ruinous levels of competition. By some metrics, takeover targets look cheap right now......»»

Category: topSource: washpostApr 1st, 2019